Corundum Open Innovation

Corundum Open Innovation is a venture capital firm based in Herzliya, Israel, founded in 2015. It invests in ICT and life sciences companies, primarily in Israeli high-tech, and supports portfolio firms with hands-on business development. The firm provides access to the high-tech ecosystem, market insights, and go-to-market strategies, along with introductions to top talent and key business partners to help portfolio companies scale. By combining investment with active operational support, Corundum Open Innovation aims to accelerate growth for its portfolio companies and connect them with strategic resources and opportunities within Israel’s innovation landscape.

David Ben-Ami

Venture Partner

Shlomo Kalish Ph.D

Managing Partner

4 past transactions

Theranica

Series C in 2022
Theranica is a medical device company specializing in the development of electroceuticals that utilize neuromodulation therapy combined with advanced wireless technology. The company has created a proprietary wearable solution, specifically a non-invasive 'smart' patch, designed to address various medical conditions, with a primary focus on migraine headaches. This innovative product is controlled via a smartphone app, allowing for personalized and portable treatment options. The patch features a unique 'smart' chip that delivers electrical pulses to modulate the sensory nerves beneath the skin, offering patients an effective means of managing acute migraines. Theranica's solutions aim to provide affordable care and enhance the quality of life for individuals suffering from neurological pain.

Theranica

Series B in 2019
Theranica is a medical device company specializing in the development of electroceuticals that utilize neuromodulation therapy combined with advanced wireless technology. The company has created a proprietary wearable solution, specifically a non-invasive 'smart' patch, designed to address various medical conditions, with a primary focus on migraine headaches. This innovative product is controlled via a smartphone app, allowing for personalized and portable treatment options. The patch features a unique 'smart' chip that delivers electrical pulses to modulate the sensory nerves beneath the skin, offering patients an effective means of managing acute migraines. Theranica's solutions aim to provide affordable care and enhance the quality of life for individuals suffering from neurological pain.

CathWorks

Series B in 2017
CathWorks is a medical technology company that applies computational science platforms to enhance percutaneous coronary intervention (PCI) therapy decisions. It offers CathWorks FFRangio, a non-invasive device delivering objective multi-vessel physiologic measurements to optimize and confirm intra-procedural PCI therapies.

Theranica

Series A in 2017
Theranica is a medical device company specializing in the development of electroceuticals that utilize neuromodulation therapy combined with advanced wireless technology. The company has created a proprietary wearable solution, specifically a non-invasive 'smart' patch, designed to address various medical conditions, with a primary focus on migraine headaches. This innovative product is controlled via a smartphone app, allowing for personalized and portable treatment options. The patch features a unique 'smart' chip that delivers electrical pulses to modulate the sensory nerves beneath the skin, offering patients an effective means of managing acute migraines. Theranica's solutions aim to provide affordable care and enhance the quality of life for individuals suffering from neurological pain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.